Hypoglycemia Unawareness Prevention: Targeting Glucagon Production
Abstract
Insulin-dependent individuals with diabetes are at risk for a severe hypoglycemic event that may predispose them to several repeat episodes during which the normal counter regulatory mechanisms that protect against hypoglycemia fail to be activated. This state of hypoglycemia unawareness is characterized by a failure of glucagon release, preventing mobilization of endogenous glucose stores from the liver. We describe the discovery of a novel hormone, produced in pancreatic delta cells, which stimulates glucagon production and release, particularly under low glucose conditions. We hypothesize that this hormone, called neuronostatin, may be effective as a co-therapy with insulin to prevent repeated, potentially fatal episodes of recurrent hypoglycemia.
Recommended Citation
W. K. Samson et al., "Hypoglycemia Unawareness Prevention: Targeting Glucagon Production," Physiology and Behavior, vol. 162, pp. 147 - 150, Elsevier, Jan 2016.
The definitive version is available at https://doi.org/10.1016/j.physbeh.2016.04.012
Department(s)
Biological Sciences
Keywords and Phrases
Glucagon; Hypoglycemia; Insulin; Neuronostatin
International Standard Serial Number (ISSN)
1873-507X; 0031-9384
Document Type
Article - Journal
Document Version
Citation
File Type
text
Language(s)
English
Rights
© 2025 Elsevier, All rights reserved.
Publication Date
15 Jan 2016
PubMed ID
27080082

Comments
National Institutes of Health, Grant 121456